Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight because OTIS operates a capital-intensive manufacturing and installation business alongside a high-margin recurring service portfolio, making earnings quality, cash conversion, and leverage each critical to assessing financial trajectory.

Composite Trajectory: Mixed

Annual earnings show divergent trends: operating profit rose 6% in 2025 but net income fell 16% due to a higher tax rate and an interest expense swing. Cash generation from operations has been stable near $1.6 billion for three years. The balance sheet shows declining cash (from $2.3 billion to $1.1 billion to $813 million) and rising gross leverage, though net leverage ratios have improved. The six-month 2026 interim shows operating profit and operating cash flow improvement, but the annual picture remains mixed.

2. Red Flags

• Net income attributable to Otis fell 16% to $1,384 million in 2025 from $1,645 million in 2024 despite a 6% rise in operating profit, driven by the effective tax rate jumping to 24.8% from 15.0% and interest expense swinging to $196 million from $31 million income (10-K 2025-12-31, Consolidated Statements of Operations).
• SG&A expense rose 6.3% to $1,979 million (13.7% of sales) in 2025, propelled by UpLift restructuring ($76 million) and other restructuring ($54 million) versus $31 million and $40 million in 2024 (10-K 2025-12-31, MD&A – Selling, General and Administrative).
• New Equipment organic sales declined 7% in 2025, with operating margin contracting 130 bps to 4.8% (10-K 2025-12-31, Segment Review – New Equipment).
• Cash and cash equivalents dropped 52% from $2,300 million at end-2024 to $1,096 million at end-2025, and further to $813 million at June 30, 2026 (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
• Total debt to total capitalization increased from 235% to 305% in 2025 (10-K 2025-12-31, MD&A – Liquidity and Financial Condition).
• Accumulated other comprehensive loss widened from -$745 million to -$1,087 million in 2025, largely from foreign currency translation losses (10-K 2025-12-31, Consolidated Statements of Changes in Equity).
• "Non-recurring" items recur: UpLift transformation costs ($16 million, $65 million, $69 million in 2023‑2025), Separation-related adjustments ($177 million in 2024, $70 million in 2025, $61 million in H1 2025), and German tax indemnity adjustments ($194 million in 2024, $67 million additional in 2025) (10-K 2025-12-31, MD&A – Other Income (Expense), Net; Note 1, Note 15, Note 20).
• Derivative settlement cash flows swung to a $204 million outflow in 2025 from a $49 million inflow in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: Annual revenue was essentially flat across 2023‑2025 ($14.2 billion, $14.3 billion, $14.4 billion) with gross margin expanding 80 bps to 30.3% (10-K 2025-12-31, Consolidated Statements of Operations). Operating profit declined 8% in 2024 then recovered 6% in 2025 to $2,133 million (14.8% margin) (10-K 2025-12-31, Consolidated Statements of Operations). However, net income attributable to Otis fell 16% in 2025 to $1,384 million due to a higher effective tax rate (24.8% vs 15.0%) and interest expense of $196 million versus $31 million income in 2024 (10-K 2025-12-31, Consolidated Statements of Operations). Segment divergence persists: New Equipment sales and margin declined (organic -7%, margin 4.8%) while Service grew (organic +5%, margin 25.1%) (10-K 2025-12-31, Segment Review). The six months ended June 30, 2026 shows improvement: operating profit rose 16% to $1,114 million (15.0% margin) and net income attributable rose 21% to $768 million (10-Q 2026-06-30, MD&A – Segment Review; Noncontrolling Interest table). Quarterly Q2 2026 operating profit grew 5% but margin dipped 30 bps to 14.9% (10-Q 2026-06-30, MD&A – Segment Review).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Stable

Overall Assessment: Net cash from operating activities has been remarkably stable for three full years: $1,627 million (2023), $1,563 million (2024), $1,596 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Capital expenditures remained modest and steady ($138 million, $126 million, $152 million), yielding consistent free cash flow near $1.44 billion annually (10-K 2025-12-31, Consolidated Statements of Cash Flows). Investing cash flow turned more negative in 2025 (-$406 million) due to $204 million net derivative settlement outflows versus a $49 million inflow in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing outflows surged to $2.4 billion in 2025 from $309 million in 2024, driven by $1.3 billion debt repayment and $809 million share repurchases (10-K 2025-12-31, Consolidated Statements of Cash Flows). In the six months ended June 30, 2026, operating cash flow jumped to $680 million from $405 million a year earlier, aided by working capital timing and lower restructuring payments (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows; MD&A – Discussion of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Liquidity deteriorated: cash fell from $2,300 million (2024) to $1,096 million (2025) to $813 million (June 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Total debt declined slightly from $8,324 million to $7,956 million in 2025 but rose to $8,436 million by June 2026 (10-K 2025-12-31, MD&A – Liquidity; 10-Q 2026-06-30, MD&A – Liquidity). Net debt increased from $6,024 million to $6,860 million to $7,623 million over the same periods (same sources). Shareholders' equity remained deeply negative and worsened from -$4,785 million to -$5,346 million to -$5,560 million, driven by treasury stock expansion (-$3,390 million to -$4,198 million) and accumulated other comprehensive losses (-$745 million to -$1,087 million) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Gross leverage (total debt/total capitalization) rose from 235% to 305% in 2025 then eased to 293% in June 2026; net leverage (net debt/net capitalization) improved from 486% to 453% to 370% (10-K 2025-12-31, MD&A – Liquidity; 10-Q 2026-06-30, MD&A – Liquidity). Working capital components moved modestly: receivables up 8% to $3,688 million, inventories up 10% to $613 million, payables up 14% to $2,142 million in 2025 (10-K 2025-12-31, Consolidated Balance Sheets).

6. Data Gaps

• Full 2023 balance sheet (total debt, cash, equity) not provided in the 10-K excerpt, limiting three-year balance sheet trend analysis.
• Quarterly (stand-alone) cash flow statements for Q1 2026, Q3 2025, and Q2 2025 are not included; only six-month aggregates are available in the 10-Qs.
• Free cash flow is not explicitly reported; it must be derived from operating cash flow minus capital expenditures.
• Segment operating profit for 2023 includes restructuring costs, while 2024‑2025 excludes them, impairing direct comparability (10-K 2025-12-31, Note 21).
• Full-year 2026 results are not yet available.
• Detailed breakdown of "Other current assets" and "Other long-term liabilities" for interim periods not fully disclosed in 10-Qs.